By Author
  By Title
  By Keywords

November 1981, Volume 31, Issue 11

Original Article

An Assessment of Buprenorphine as an Analgesic

S.A.R. Gardezi  ( Department of Surgery, North Surgical Unit No. 1, Mayo Hospital, King Edward Medical College, Lahore-Pakistan. )
H. Shafique Ahmed  ( Department of Surgery, North Surgical Unit No. 1, Mayo Hospital, King Edward Medical College, Lahore-Pakistan. )
Abdul Majid Chaudhary  ( Department of Surgery, North Surgical Unit No. 1, Mayo Hospital, King Edward Medical College, Lahore-Pakistan. )
Ijaz Ahmed  ( Department of Surgery, North Surgical Unit No. 1, Mayo Hospital, King Edward Medical College, Lahore-Pakistan. )


Buprenorphine has been shown to be an effective analgesic agent. In this trial buprenorphine was found as an effective analgesic agent in most of surgical emergencies; same was true for post operative cases. The duration of analgesia in this study was found to be nearly 8 hours as compared with morphine which was 5-1/2 hours. In another study after operations (Royll and Versichelas, 1976) the duration of analgesia following 4 ug/kg of buprenorphine was at least 6 hours. The drug has a low frequency of side effects. Respiratory depression is known to occur with buprenorphine. In a study of Orwin and Robson (1976) the respiratory effects of equianalgesic doses of buprenorphine and morphine were similar (JPMA 31:250, 1981).


Buprenorphine is a new synthetic analgesic agent derived from thebaine (Lewis, 1974) and is closely related in structure to morphine. Boura and Fitzgerald (1966) found buprenorphine to be 50 times more potent compared with morphine in mice, rat and dog. Clinical trials in man (Hovell, 1976) showed that buprenorphine is safe, potent and long acting analgesic which was equally useful in the treatment of pain after surgery.
Prolonged administration in monkeys and mice does not produce addiction. Peak concentrations in man are found 10-30 minutes after M injection. Excretion of buprenorphine is relatively slow and the principal route is faeces. It is mata-bolised in the liver but mostly unchanged buprenorphine is found in the faeces.
Object of the Trial
The object of the trial was to assess:
1. The efficacy of buprenorphine as an analgesic in all sorts of general surgical emergencies.
2. A comparative study of buprenorphine with morphine as analgesic in post operative patients. In the latter group buprenorphine and morphine were compared for the duration of pain relief in the post operative period and adverse reactions if any of both the drugs were noted.

Methods and Material

A total number of 150 patients were admitted to this trial. The cases were divided in two groups.
1 General assessment group consisted of fifty non-operative random patients who reported to the casualty department with acute illness, trauma and colics to assess the analgesic activitiy of buprenorphine.
2. In the comparative group (fifty pairs) one hundred of post operative patients were studied for comparison between buprenor-phine and morphine. All the patients were selected from the North Surgical Ward, Mayo Hospital, Lahore. The age difference between the pairs was not more than five years, and they belonged to the same sex. Similar operations were performed by the same group of surgeons. The anaesthesia techniques and procedures were also similarly standardised.
All patients who were mentally somewhat unstable or considered to be malingerers were excluded from the trial. The age varied between 12 and 72 years (Table 1).

Fifty of the post-operative cases received buprenorphine 0.3 mg IM and the comparative group of fifty patients received 10 mg. morphine 1/2 an hour after anaesthesia. Non-operative cases received in the emergency room buprenorphine as a primary analgesic. The sex ratio is given in table 2.

Table 3A shows the general breakdown of random patients received in the emergency who were given buprenorphine as a primary analgesic

Table 3B shows the breakdown data of the post operative cases selected for the comparative study of buprenorphine versus morphine for their analgesic effect.
The above patients were monitored carefully for a period of 10 hours post-operatively observing the following protocol by the senior and junior Registrar and competent senior Nursing Staff:
1. Hourly pulse
2. Hourly blood pressure
3. Onset of analgesic effect
4. Recurrence of pain after first injection.
Onset of analgesic effect in various patients in the general assessment groups is given in .
For the duration of relief from pain their state of comfort and state of analgesia were carefully observed by the Nursing Staff on duty The observation was stopped at the end of 10th hour or earlier if a second injection had to be given. The mean of the duration was taken as pain-free period. The response was comparatively studied applying the following:
A Good B Satisfactory
C Poor
Good response meant that the patient was completely pain free; satisfactory response meant a relative freedom from pain whereas poor response denoted poor relief of pain or imperfect analgesia.

The results are shown in Table 5 and Fig. 2.

The untoward side effects were recorded.

Table 6 illustrates a list of complications along-with number of patients and their percentage who received 0.3 mg. Buprenorphine compared with the group receiving 10 mg of morphine.
No deaths were recorded during the trial. A total of 26% of patients receiving buprenorphine showed side effects while 30% patients who were given morphine showed the same. Out of 13 patients receiving buprenorphine who showed untoward effects, 7 patients needed treatment. Out of 15 patients who showed adverse reactions to morphine 8 patients needed treatment.
In our study respiratory depression was found to be potentiated by anaesthetic agents like Halo-thene Brevedil and Flexedil. This calls for a care in its use in conjunctioc with anaestheric agents.
Whereas we recommend buprenorphine as a safe and effective analgesic in acute pain and as post operative analgesic; its use as an adjunct to anaesthetic agents is not recommended.


The authors are grateful for the help and assistance of Dr. Tanveer A. Naveed Bhatti, Registrar, N.S.W., Dr. S.N.H Kazmi, M.O., Dr. Modood Ali, Senior House Surgeon, N.S.W., Dr. S. Athar Ali Bokhari, Senior House Surgeon, N.S.W., and staff Nurse Nusrat Saeeda and Staff Nurse Zaib-un-Nisa. Thanks are also due to Messrs Abdul Ghaffar Naeem and Muhammad Aslam Javed of Postgraduate Medical Institute, Lahore.


1. Boura, A.L. and Fitzgerald, A.E. (1966) The pharmacology of N-(CyclopropyIemethyl)-19 isopentylnosovinol hydrochloride. A potent and long lasting Central depressant. Br. J. Pharmacol., 26:307.
2. Hovell, B.C. (1976) Buprenorphine. Clinical trial in Postoperative pain by intramuscular route. Sixth World Cong. Anaesthesiol 387 18 Excerpta Medica International Congress Series.
3. Lewis, J.W. Ring C-bridged derivatives of thebaine and oripavine. Narcotic antagonists, in advances in biochemical psychopharmacology eds M.C. Villarreal. New York, Ravan Press, Vol. 8 pp. 123, 1974.
4. Orwin, J.M. and Robson, P.J. (1976) Effects of buprenorphine and morphine on respiration following administration by the intramuscular route in man. VI Congr. Mond. Anaesthesiol Section S.S.
5. Roily, G. and Versichelen, L. (1976) A first experience with a new analgesic drug: Buprenorphine. Sixth World Congress of Anesthesiology, 387, 19. Excerpta Medica, Inter national Congress Series.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: